SF
ARNA

Synovus Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Synovus Financial’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed – – 2232
2020
Q1 		$0 Buy
+8
New +$367 ﹤0.01% 2256
2015
Q4 		– Sell
-150
Closed -$3K – 1056
2015
Q3 		$3K Hold
150
– – ﹤0.01% 911
2015
Q2 		$7K Hold
150
– – ﹤0.01% 881
2015
Q1 		$7K Hold
150
– – ﹤0.01% 913
2014
Q4 		$5K Hold
150
– – ﹤0.01% 949
2014
Q3 		$6K Hold
150
– – ﹤0.01% 889
2014
Q2 		$9K Hold
150
– – ﹤0.01% 818
2014
Q1 		$9K Hold
150
– – ﹤0.01% 830
2013
Q4 		$9K Hold
150
– – ﹤0.01% 783
2013
Q3 		$8K Buy
+150
New +$10.1K ﹤0.01% 770

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Synovus Financial's ARNA Position: Q2 2020 in Review

Synovus Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2020, closing a stake of 8 shares.

Synovus Financial first reported a position in ARNA in Q3 2013 and held it in 10 quarters. The position peaked at $9K in Q2 2014. 247 funds tracked by Wall St. Rank hold ARNA as of Q2 2020.

  • Synovus Financial reported no remaining Arena Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Synovus Financial sold 8 Arena Pharmaceuticals Inc shares in Q2 2020.
  • Synovus Financial first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 10 quarters.
  • Synovus Financial's Arena Pharmaceuticals Inc position peaked at $9K in Q2 2014.
  • 247 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2020.

Based on Synovus Financial's 13F filing for Q2 2020, filed 10 Aug 2020.